Agenus Inc (NASDAQ: AGEN) on Friday, soared 10.48% from the previous trading day, before settling in for the closing price of $3.15. Within the past 52 weeks, AGEN’s price has moved between $2.50 and $19.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 46.68% over the last five years. The company achieved an average annual earnings per share of 11.83%. With a float of $22.36 million, this company’s outstanding shares have now reached $23.46 million.
The firm has a total of 389 workers. Let’s measure their productivity. In terms of profitability, gross margin is 68.67%, operating margin of -61.67%, and the pretax margin is -145.41%.
Agenus Inc (AGEN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Agenus Inc is 4.68%, while institutional ownership is 33.68%. The most recent insider transaction that took place on Feb 15 ’24, was worth 324,050. In this transaction an insider of this company bought 500,000 shares at a rate of $0.65, taking the stock ownership to the 625,969 shares.
Agenus Inc (AGEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.83% per share during the next fiscal year.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Agenus Inc (AGEN) is currently performing well based on its current performance indicators. A quick ratio of 0.19 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.00, a number that is poised to hit -2.64 in the next quarter and is forecasted to reach -8.91 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Analysing the last 5-days average volume posted by the [Agenus Inc, AGEN], we can find that recorded value of 0.25 million was lower than the volume posted last year of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 45.90%. Additionally, its Average True Range was 0.27.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 24.32%, which indicates a significant decrease from 80.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.79% in the past 14 days, which was lower than the 85.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.19, while its 200-day Moving Average is $7.45. Now, the first resistance to watch is $3.60. This is followed by the second major resistance level at $3.71. The third major resistance level sits at $3.93. If the price goes on to break the first support level at $3.27, it is likely to go to the next support level at $3.05. Should the price break the second support level, the third support level stands at $2.94.
Agenus Inc (NASDAQ: AGEN) Key Stats
Market capitalization of the company is 81.64 million based on 23,459K outstanding shares. Right now, sales total 156,310 K and income totals -245,760 K. The company made 25,110 K in profit during its latest quarter, and -66,390 K in sales during its previous quarter.
